Download PDF
1 / Pages

Other users also viewed these articles

Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease Alejandro Valencia-Rodríguez; Alfonso Vera-Barajas; Norberto C. Chávez-Tapia; Misael Uribe; Nahum Méndez-Sánchez;
Ann Hepatol. 2020;19:227-9
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms Xiaoyi Wang; Zhen Yang; Ying Ran; Long Li; Bangmao Wang; Lu Zhou;
Ann Hepatol. 2023;28:
A landscape of liver cirrhosis and transplantation in Mexico: Changing leading causes and transplant as response Icela Palma-Lara; María Guadalupe Ortiz-López; José Bonilla-Delgado; Juanita Pérez-Escobar; Ricardo Godínez-Aguilar; Claudia Luévano-Contreras; Ana María Espinosa-García; Javier Pérez-Durán; Patricia García Alonso-Themann; Manuel Nolasco-Quiroga; Javier Flores-Estrada; Paulina Carpinteyro-Espin; Daniel Juárez-Ascencio; Nayeli Goreti Nieto-Velazquez; Carmen Palacios-Reyes;
10.1016/j.aohep.2024.101562